SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | -99.7% | 13 | -99.9% | 0.00% | -100.0% |
| Q4 2015 | $741,000 | -7.8% | 15,560 | -3.7% | 0.02% | -15.8% |
| Q3 2015 | $804,000 | -19.7% | 16,160 | -12.5% | 0.02% | -17.4% |
| Q2 2015 | $1,001,000 | +15.2% | 18,460 | +0.1% | 0.02% | +35.3% |
| Q1 2015 | $869,000 | -1.0% | 18,450 | -1.6% | 0.02% | 0.0% |
| Q4 2014 | $878,000 | +4.9% | 18,750 | +16.7% | 0.02% | 0.0% |
| Q3 2014 | $837,000 | -4.1% | 16,060 | 0.0% | 0.02% | -10.5% |
| Q2 2014 | $873,000 | -9.9% | 16,060 | 0.0% | 0.02% | -5.0% |
| Q1 2014 | $969,000 | +149.1% | 16,060 | +66.2% | 0.02% | +150.0% |
| Q4 2013 | $389,000 | +211.2% | 9,662 | +249.8% | 0.01% | +166.7% |
| Q3 2013 | $125,000 | +40.4% | 2,762 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $89,000 | – | 2,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |